Parnell Financial Statements From 2010 to 2026

Parnell Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Parnell Pharmaceuticals' valuation are provided below:
Parnell Pharmaceuticals Holdings does not presently have any trending fundamental ratios for analysis.
Check Parnell Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Parnell Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Parnell financial statements analysis is a perfect complement when working with Parnell Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Parnell Pharmaceuticals Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Parnell Pharmaceuticals Holdings Company Return On Asset Analysis

Parnell Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Parnell Pharmaceuticals Return On Asset

    
  0.0647  
Most of Parnell Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Parnell Pharmaceuticals Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Parnell Pharmaceuticals Holdings has a Return On Asset of 0.0647. This is 100.74% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 146.21% lower than that of the firm.

Parnell Pharmaceuticals Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Parnell Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Parnell Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Parnell Pharmaceuticals competition to find correlations between indicators driving Parnell Pharmaceuticals's intrinsic value. More Info.
Parnell Pharmaceuticals Holdings is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Parnell Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Parnell Pink Sheet

If you are still planning to invest in Parnell Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Parnell Pharmaceuticals' history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamental Analysis
View fundamental data based on most recent published financial statements
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes